Turning a cancer scan tracer into a potential Tumor-Killing treatment
NCT ID NCT02130492
Summary
This early-stage study is testing whether a very high dose of a radioactive sugar molecule (FDG), commonly used in PET scans to find cancer, can be used to treat it. The trial is for adults with advanced cancer that has spread and is no longer responding to standard treatments. Researchers aim to see if the cancer cells, which absorb a lot of this sugar, can be killed by the radiation it delivers, while being safe for the patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Medical College of Cornell University
New York, New York, 10024, United States
Conditions
Explore the condition pages connected to this study.